Patents by Inventor Dan Gibson

Dan Gibson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTICANCER AGENTS
    Publication number: 20220251126
    Abstract: The claimed subject matter provides for a method for conjugating an active material to a Pt complex.
    Type: Application
    Filed: August 5, 2020
    Publication date: August 11, 2022
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Dan GIBSON, Amrita SARKAR
  • PT(IV) PRODRUGS
    Publication number: 20190290656
    Abstract: The invention provides a novel class of Pt-based anticancer compounds exhibiting multiple anticancer activity.
    Type: Application
    Filed: December 29, 2016
    Publication date: September 26, 2019
    Inventor: Dan Gibson
  • Pt (IV) derivatives and nanocarriers comprising them
    Patent number: 10239903
    Abstract: Provided are Pt (IV) lipophilic derivatives for improved drug performance in cancer therapy, as well as nanocarriers including the same.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: March 26, 2019
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Simon Benita, Taher Nassar, Dan Gibson, Aiman Abu Ammar
  • PT (IV) DERIVATIVES AND NANOCARRIERS COMPRISING THEM
    Publication number: 20170081352
    Abstract: Provided are Pt (IV) lipophilic derivatives for improved drug performance in cancer therapy, as well as nanocarriers including the same.
    Type: Application
    Filed: April 30, 2015
    Publication date: March 23, 2017
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Simon BENITA, Taher NASSAR, Dan GIBSON, Aiman Abu AMMAR
  • Positively-charged peptide nucleic acid analogs with improved properties
    Patent number: 7671036
    Abstract: The present invention relates to novel types of peptide nucleic acids (PNAS) with improved properties. In particular, it relates to positively charged PNA units having an ethylene linker between the backbone and the nucleobase, to oligonucleotide analogs comprising these units, to oligomers comprising these units, and to the use of positively charged PNAs as novel delivery agents with therapeutic and diagnostic applications including for antisense therapy.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: March 2, 2010
    Assignee: Yissum Research Development Company of The Hebrew University of Jerusalem
    Inventors: Jehoshua Katzhendler, Ada Schlossman, Yousuf Najajreh, Dan Gibson
  • Platinum complexes and their use in therapy
    Patent number: 7122668
    Abstract: The present invention concerns novel platinum complexes in which at least one of the amine ligand is a non-planar heterocyclic aliphatic amine. The platinum complexes may be in a trans or cis configuration and were found to posses therapeutic activites. Thus, the present concerns novel platinum complexes, pharmaceutical compositions comprising them and other uses thereof.
    Type: Grant
    Filed: August 21, 2002
    Date of Patent: October 17, 2006
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Yechezkel Barenholz, Dan Gibson, Yousef Najajreh, Elena Khazanov
  • Platinum complexes and their use in cancer treatment
    Publication number: 20050090478
    Abstract: The present invention concerns novel platinum complexes in which at least one of the amine ligand is a non-planar heterocyclic aliphatic amine. The platinum complexes may be in a trans or cis configuration and were found to posses therapeutic activites. Thus, the present concerns novel platinum complexes, pharmaceutical compositions comprising them and other uses thereof.
    Type: Application
    Filed: August 21, 2002
    Publication date: April 28, 2005
    Inventors: Yechezkel Barenholz, Dan Gibson, Yousef Najajreh, Elena Khazanov
  • Positively-charged peptide nucleic acid analogs with improved properties
    Publication number: 20040034043
    Abstract: The present invention relates to novel types of peptide nucleic acids (PNAS) with improved properties. In particular, it relates to positively charged PNA units having an ethylene linker between the backbone and the nucleobase, to oligonucleotide analogs comprising these units, to oligomers comprising these units, and to the use of positively charged PNAs as novel delivery agents with therapeutic and diagnostic applications including for antisense therapy.
    Type: Application
    Filed: June 2, 2003
    Publication date: February 19, 2004
    Inventors: Jehoshua Katzhendler, Ada Schlossmann, Yousuf Najajreh, Dan Gibson